Literature DB >> 6151960

Clinical and serological diagnosis of Nephropathia epidemica, the mild type of haemorrhagic fever with renal syndrome.

J Lähdevirta, J Savola, M Brummer-Korvenkontio, R Berndt, R Illikainen, A Vaheri.   

Abstract

The serological diagnosis of Nephropathia epidemica (NE), the mild European type of haemorrhagic fever with renal syndrome (HFRS), was studied by means of an indirect immunofluorescent antibody technique (IFAT) in a large outbreak in Finland (morbidity 1.4/1000 population). Acetone-fixed sections of lung of bank voles (Clethrionomys glareolus) naturally infected with Puumala virus served as antigen. Altogether 65 patients were followed serologically for up to 20 months. Serological results obtained by NE-IFAT were compared with the clinical diagnosis of NE. Of the 41 clinically accepted NE cases 40 were serologically positive. Use of the NE-IFAT serological test allowed the diagnosis to be made in seven patients for whom the clinical data were not sufficient for diagnosing NE. The antibody response in NE often appears to be slower than that against Hantaan virus. Practical recommendations are given for the clinical and serological diagnosis of the milder forms of HFRS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151960     DOI: 10.1016/s0163-4453(84)90464-x

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  10 in total

1.  Cognitive impairment after acute encephalitis: comparison of herpes simplex and other aetiologies.

Authors:  L Hokkanen; E Poutiainen; L Valanne; O Salonen; M Iivanainen; J Launes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

2.  The clinical spectrum of human hantavirus infection in Somerset, UK.

Authors:  J V Pether; G Lloyd
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

3.  Anti-endothelial cell antibodies in nephropathia epidemica and other viral diseases.

Authors:  A G Wangel; M Temonen; M Brummer-Korvenkontio; A Vaheri
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

4.  Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies.

Authors:  J Arikawa; J S Yao; K Yoshimatsu; I Takashima; N Hashimoto
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Puumala virus antibody and immunoglobulin G avidity assays based on a recombinant nucleocapsid antigen.

Authors:  H Kallio-Kokko; O Vapalahti; K Hedman; M Brummer-Korvenkontio; A Vaheri
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

6.  Ecological and epidemiological data on Hantavirus in bank vole populations in Belgium.

Authors:  R Verhagen; H Leirs; E Tkachenko; G van der Groen
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 7.  Amending Koch's postulates for viral disease: When "growth in pure culture" leads to a loss of virulence.

Authors:  Joseph Prescott; Heinz Feldmann; David Safronetz
Journal:  Antiviral Res       Date:  2016-11-08       Impact factor: 5.970

8.  Spatial dynamics of a zoonotic orthohantavirus disease through heterogenous data on rodents, rodent infections, and human disease.

Authors:  Sophie O Vanwambeke; Caroline B Zeimes; Stephan Drewes; Rainer G Ulrich; Daniela Reil; Jens Jacob
Journal:  Sci Rep       Date:  2019-02-20       Impact factor: 4.379

9.  Prevalence of Hantaviruses Harbored by Murid Rodents in Northwestern Ukraine and Discovery of a Novel Puumala Virus Strain.

Authors:  Evan P Williams; Mariah K Taylor; Iryna Demchyshyna; Igor Nebogatkin; Olena Nesterova; Iryna Khuda; Lyudmyla Chernenko; Oleksandra A Hluzd; Vira V Kutseva; Gregory E Glass; Nataliia Yanko; Colleen B Jonsson
Journal:  Viruses       Date:  2021-08-18       Impact factor: 5.048

10.  Modelling zoonotic diseases in humans: comparison of methods for hantavirus in Sweden.

Authors:  Caroline B Zeimes; Gert E Olsson; Clas Ahlm; Sophie O Vanwambeke
Journal:  Int J Health Geogr       Date:  2012-09-17       Impact factor: 3.918

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.